FDA Issues Alert for Medtronic Esophageal Monitoring Devices
The agency warns of potential high-risk issues with Bravo CF delivery systems following reports of 184 serious injuries.
The agency warns of potential high-risk issues with Bravo CF delivery systems following reports of 184 serious injuries.
The company is advising users to keep devices plugged into AC power following a software anomaly that may cause false battery readings and unexpected shutdowns.
The agency exceeded its three-month termination timeline for 74% of recalls during fiscal years 2020-2024, due to staff constraints that limited oversight activities, the report finds.
The agency warns of potential high-risk issues with Bravo CF delivery systems following reports of 184 serious injuries.
GE HealthCare is updating use instructions after reports certain systems may not switch to battery mode during AC power loss, potentially disrupting ventilation and agent delivery.
Read MoreThe company is pulling the Life2000 system from the market after finding a vulnerability that could allow unauthorized changes to ventilation settings.
Read MoreThe FDA issued a safety alert after users reported nitric oxide dose fluctuations, potentially leading to hypoxemia or increased pulmonary artery pressure.Â
Read MoreThe issue affects certain systems in which ice may obstruct the venting system, potentially leading to dangerous overpressure events if a magnet quench occurs.
Read MoreThe alert follows reports of damaged patient connectors that could introduce micro-air bubbles, trigger air-in-line alarms, and lead to treatment delays or blood loss during hemodialysis.
Read MoreThe action addresses a discrepancy between the device’s labeled and actual performance at high flow rates, which could pose a risk of patient hypothermia.
Read MoreThe alert links purge retainer failures to potential pump stops and loss of hemodynamic support; the manufacturer is planning a service update.